Sonnet biotherapeutics provides fiscal year 2023 business and financial update

Princeton, nj / accesswire / december 14, 2023 / sonnet biotherapeutics holdings, inc. (nasdaq:sonn) ("sonnet" or the "company"), a biopharmaceutical company developing innovative targeted biologic drugs focused on oncology, announced today its financial results for the fiscal year ended september 30th, 2023 and provided a business update. "sonnet has had a very productive year, exemplified by important achievements across our pipeline.
SONN Ratings Summary
SONN Quant Ranking